speb/financial-data huggingface dataset:
Financial ratios for AEV.AX — annual report dated 2021-06-30
Operating income: -1601895.4887218045
Net income: -1583427.819548872
Capital expenditures: 877391.7293233082
Depreciation & amortization: 25724.812030075187
Net tangible assets: 6847733.834586466
Owner earnings: -2435094.736842105
Return on net tangible assets (%): -35.56059268166869
Buffett classification: The Gruesome
Stock price: 0.007518796992481203
Shares outstanding: 5430089695
Book value: 6888105.263157895
P/B ratio: 5.927281960402481
Market cap (USD): 40827742.06766917
Debt to equity: 0.2766989623607439
Current ratio: 4.8436249906917865
Quick ratio: 4.8436249906917865
Free cash flow (dilution-adjusted): -2214627.067669173
Buyback yield (%): 5.855061663028386
Retained earnings: -112556069.17293233
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.868618223057021
Rule of 40 score: 0
Financial ratios for AEV.AX — annual report dated 2022-06-30
Operating income: -1729320
Net income: -1982902.7586206896
Capital expenditures: 1177592.4137931035
Depreciation & amortization: 23787.58620689655
Net tangible assets: 4369788.9655172415
Owner earnings: -3136707.5862068967
Return on net tangible assets (%): -71.78167208895435
Buffett classification: The Gruesome
Stock price: 0.006896551724137932
Shares outstanding: 5430089695
Book value: 4428409.655172413
P/B ratio: 8.456510884112832
Market cap (USD): 37448894.448275864
Debt to equity: 0.5013659453366461
Current ratio: 1.5091372096776097
Quick ratio: 1.5091372096776097
Interest coverage ratio: -10.98307980044414
Free cash flow (dilution-adjusted): -2280162.7586206896
Buyback yield (%): 0.1357104654603684
Retained earnings: -105223986.89655173
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -21.376991086164182
Rule of 40 score: 0
Financial ratios for AEV.AX — annual report dated 2023-06-30
Operating income: -1983384.7682119205
Net income: -2117682.119205298
Capital expenditures: 42758.94039735099
Depreciation & amortization: 12043.708609271524
Net tangible assets: 7191591.390728476
Owner earnings: -2148397.3509933776
Return on net tangible assets (%): -29.873740515390356
Buffett classification: The Gruesome
Stock price: 0.013245033112582781
Shares outstanding: 5430089695
Book value: 7191591.390728477
P/B ratio: 10.000807040746537
Market cap (USD): 71921717.81456953
Debt to equity: 0.3190183568871777
Current ratio: 0.8049681946144501
Quick ratio: 0.8049681946144501
Interest coverage ratio: -11.458905498525029
Free cash flow (dilution-adjusted): -3128668.8741721855
Buyback yield (%): 0.4558893386750953
Retained earnings: -103160583.44370861
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -22.961271731917847
Rule of 40 score: 0
Financial ratios for ALB — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 221.01
Shares outstanding: 117934651
Market cap (USD): 26064737217.51
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALB — annual report dated 2022-12-31
Total revenue: 7320104000
Gross profit: 3074587000
Operating income: 2478461000
Net income: 2815131000
Capital expenditures: 0
Operating cash flow: 1907849000
Depreciation & amortization: 300841000
Net tangible assets: 6077130000
Owner earnings: 3115972000
Return on net tangible assets (%): 51.27374270420412
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 206.36
P/E ratio: 8.645066457070737
Shares outstanding: 117934651
Book value: 8190847000
P/B ratio: 2.9712427274444266
Market cap (USD): 24336994580.36
Debt to equity: 0.40488718688067304
Current ratio: 1.8923344089689402
Quick ratio: 1.1349394293719661
Effective tax rate (%): 16.050831660806658
Interest coverage ratio: 20.154513592414595
COGS to revenue (%): 57.99804210431982
R&D to revenue (%): 0.9833330236838165
SG&A to revenue (%): 7.1603490879364555
Free cash flow (dilution-adjusted): 615729000
Buyback yield (%): 0
Retained earnings: 5601277000
Inventory turnover: 2.0450161871378607
Receivables turnover: 5.053282377825518
Capitalized R&D asset: 71981000
ROCI (R&D-adjusted, %): 19.757190257643515
FCF margin (%): 8.411478853305908
Rule of 40 score: 8.411478853305908
Financial ratios for ALB — annual report dated 2023-12-31
Total revenue: 9617203000
Gross profit: 1185909000
Operating income: 190182000
Net income: 1670543000
Capital expenditures: 0
Operating cash flow: 1326583000
Depreciation & amortization: 429944000
Net tangible assets: 7520593000
Owner earnings: 2100487000
Return on net tangible assets (%): 27.929805535281595
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 138.68
P/E ratio: 9.79033607676067
Shares outstanding: 117934651
Book value: 9665099000
P/B ratio: 1.6921893299468531
Market cap (USD): 16355177400.68
Debt to equity: 0.44287637405473035
Current ratio: 1.465236533910487
Quick ratio: 0.8582122207735963
Effective tax rate (%): 174.3861910204346
Interest coverage ratio: 1.6384830105451789
COGS to revenue (%): 87.668878363075
R&D to revenue (%): 0.8913714309659472
SG&A to revenue (%): 9.462231378499549
Free cash flow (dilution-adjusted): -864504000
Buyback yield (%): 0
Retained earnings: 6987015000
Inventory turnover: 3.901052474752312
Receivables turnover: 5.2403828444701155
Capitalized R&D asset: 133952270
ROCI (R&D-adjusted, %): 1.5045553274216452
Rosenberg metric: -26.23856295411289
FCF margin (%): -8.989141645445146
Revenue growth (%): 31.3806880339405
Rule of 40 score: 22.391546388495357
Financial ratios for ALB — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 91.96
Shares outstanding: 117934651
Market cap (USD): 10845270505.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALB — annual report dated 2024-12-31
Total revenue: 5377526000
Gross profit: 62539000
Operating income: -642229000
Net income: -1135477000
Capital expenditures: 29102000
Operating cash flow: 687876000
Depreciation & amortization: 588638000
Net tangible assets: 8148050000
Owner earnings: -575941000
Return on net tangible assets (%): -7.06845196089862
Buffett classification: The Gruesome
Stock price: 83.91
Shares outstanding: 117934651
Book value: 10199688000
P/B ratio: 0.9702156149688108
Market cap (USD): 9895896565.41
Debt to equity: 0.3544891765316743
Current ratio: 1.953893892794376
Quick ratio: 1.189816340395756
Interest coverage ratio: -3.8777495335680086
COGS to revenue (%): 98.83703026261519
R&D to revenue (%): 1.6126374842260178
SG&A to revenue (%): 11.493166188317824
Free cash flow (dilution-adjusted): -1024794000
Buyback yield (%): 0
Retained earnings: 5481692000
Inventory turnover: 3.537355968029944
Receivables turnover: 5.046666541536845
Capitalized R&D asset: 167909480
ROCI (R&D-adjusted, %): -4.300724259057818
Rosenberg metric: -13.104345290172061
FCF margin (%): -19.056978989966762
Revenue growth (%): -44.08430392911536
Rule of 40 score: -63.141282919082116
Financial ratios for ALB — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 83.91
Shares outstanding: 117934651
Market cap (USD): 9895896565.41
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALB — quarterly report dated 2025-03-31
Total revenue: 1076881000
Gross profit: 156299000
Operating income: 18698000
Net income: 49298000
Capital expenditures: 182624000
Operating cash flow: 547207000
Depreciation & amortization: 161754000
Net tangible assets: 8192356000
Owner earnings: 28428000
Return on net tangible assets (%): 0.3470064045068354
Capex to operating income (%): 976.7033907369772
Buffett classification: The Gruesome
Stock price: 70.6
P/E ratio: 42.22375329932248
Shares outstanding: 117934651
Book value: 10274342000
P/B ratio: 0.8103863352611776
Market cap (USD): 8326186360.599999
Debt to equity: 0.35432741094271536
Current ratio: 2.1123723444797426
Quick ratio: 1.2605049493595173
Interest coverage ratio: 0.38177103538395574
COGS to revenue (%): 85.4859543440733
R&D to revenue (%): 1.3092440111767225
SG&A to revenue (%): 11.468490947467732
Free cash flow (dilution-adjusted): 357617000
Buyback yield (%): 0
Retained earnings: 5433704000
Inventory turnover: 0.5557845040193435
Receivables turnover: 1.3330127312450872
Capitalized R&D asset: 14099000
ROCI (R&D-adjusted, %): 0.18645829489892823
FCF margin (%): 33.20859036420923
Rule of 40 score: 33.20859036420923
Financial ratios for ALB — quarterly report dated 2025-06-30
Total revenue: 1329992000
Gross profit: 196876000
Operating income: 51975000
Net income: 35193000
Capital expenditures: 119628000
Operating cash flow: -9027000
Depreciation & amortization: 168731000
Net tangible assets: 8334651000
Owner earnings: 84296000
Return on net tangible assets (%): 1.0113920786845185
Capex to operating income (%): 230.16450216450215
Buffett classification: The Gruesome
Stock price: 61.83
P/E ratio: 86.30386042690938
Shares outstanding: 117934651
Book value: 10498984000
P/B ratio: 0.6945338207325584
Market cap (USD): 7291899471.33
Debt to equity: 0.35408492859880536
Current ratio: 2.3106082519909896
Quick ratio: 1.469015029357098
Interest coverage ratio: 1.0407697390816797
COGS to revenue (%): 85.19720419370942
R&D to revenue (%): 0.9356447256825604
SG&A to revenue (%): 9.959232837490752
Free cash flow (dilution-adjusted): -138757000
Buyback yield (%): 0
Retained earnings: 5367257000
Inventory turnover: 0.6905349117113823
Receivables turnover: 1.5118046509301633
Capitalized R&D asset: 21890330
ROCI (R&D-adjusted, %): 0.36169755779443713
Rosenberg metric: 2.878005532307256
FCF margin (%): -10.43291989726254
Revenue growth (%): 23.504082623799658
Rule of 40 score: 13.071162726537118
Financial ratios for ALB — quarterly report dated 2025-09-30
Total revenue: 1307829000
Gross profit: 117610000
Operating income: -33641000
Net income: -147941000
Capital expenditures: 1900000
Operating cash flow: 355602000
Depreciation & amortization: 164483000
Net tangible assets: 8275295000
Owner earnings: 14642000
Buffett classification: The Gruesome
Stock price: 80.43
Shares outstanding: 117934651
Book value: 10269058000
P/B ratio: 0.9236956281608305
Market cap (USD): 9485483979.93
Debt to equity: 0.36371768471850097
Current ratio: 2.2729588603331212
Quick ratio: 1.5081598679410806
Interest coverage ratio: -0.6601581663690418
COGS to revenue (%): 91.00723412617398
R&D to revenue (%): 0.9690869372066226
SG&A to revenue (%): 10.595957116717859
Free cash flow (dilution-adjusted): 212458000
Buyback yield (%): 0
Retained earnings: 5117213000
Inventory turnover: 0.7765900528636546
Receivables turnover: 1.5547589214173456
Capitalized R&D asset: 25664150
ROCI (R&D-adjusted, %): -0.22438592100231053
Rosenberg metric: -6.369816779170685
FCF margin (%): 16.245090145577134
Revenue growth (%): -1.6664010009082761
Rule of 40 score: 14.578689144668857
Financial ratios for ALB — quarterly report dated 2025-12-31
Total revenue: 1428031000
Gross profit: 197934000
Operating income: 30253000
Net income: -401760000
Capital expenditures: 7161000
Operating cash flow: 388485000
Depreciation & amortization: 163710000
Net tangible assets: 7819475000
Owner earnings: -245211000
Return on net tangible assets (%): -3.1359010675269117
Capex to operating income (%): 23.670379797044923
Buffett classification: The Great
Stock price: 140.73
Shares outstanding: 117934651
Book value: 9781461000
P/B ratio: 1.6967755057480676
Market cap (USD): 16596943435.23
Debt to equity: 0.33703053153307055
Current ratio: 2.2291662495467297
Quick ratio: 1.5733029892483166
Interest coverage ratio: 0.5236257269454445
COGS to revenue (%): 86.13937652613984
R&D to revenue (%): 0.8529926871335426
SG&A to revenue (%): 10.889119353851562
Free cash flow (dilution-adjusted): 220877000
Buyback yield (%): 0
Retained earnings: 4613676000
Inventory turnover: 1.0430995080859276
Receivables turnover: 1.8672612657612129
Capitalized R&D asset: 24779100
ROCI (R&D-adjusted, %): 0.20547298643887194
Rosenberg metric: 6.337699226763453
FCF margin (%): 15.467241257367661
Revenue growth (%): 9.19095692173824
Rule of 40 score: 24.658198179105902
Financial ratios for ALB — annual report dated 2025-12-31
Total revenue: 5142733000
Gross profit: 668719000
Operating income: 67285000
Net income: -465210000
Capital expenditures: 32812000
Operating cash flow: 1282267000
Depreciation & amortization: 658678000
Net tangible assets: 7819475000
Owner earnings: 160656000
Capex to operating income (%): 48.76569814966189
Buffett classification: The Good
Stock price: 140.73
Shares outstanding: 117934651
Book value: 9781461000
P/B ratio: 1.6967755057480676
Market cap (USD): 16596943435.23
Debt to equity: 0.33703053153307055
Current ratio: 2.2291662495467297
Quick ratio: 1.5733029892483166
Interest coverage ratio: 0.3240292606344299
COGS to revenue (%): 86.99681667315802
R&D to revenue (%): 0.9994296806775697
SG&A to revenue (%): 10.695402619579902
Free cash flow (dilution-adjusted): 652195000
Buyback yield (%): 0
Retained earnings: 4613676000
Inventory turnover: 3.793881135040207
Receivables turnover: 6.724522178476489
Capitalized R&D asset: 137789650
ROCI (R&D-adjusted, %): 0.29950249083183667
Rosenberg metric: 6.990083025830258
FCF margin (%): 12.681875570829751
Revenue growth (%): -4.366189954265214
Rule of 40 score: 8.315685616564537
Financial ratios for ALSMA.PA — annual report dated 2022-12-31
Total revenue: 2597732.9787234045
Gross profit: 471864.8936170213
Operating income: -4251019.14893617
Net income: 3027286.170212766
Capital expenditures: 883250
Operating cash flow: 6314713.829787235
Depreciation & amortization: 1544391.4893617022
Net tangible assets: 7909844.680851065
Owner earnings: 3688427.6595744686
Return on net tangible assets (%): 46.630848118974825
Buffett classification: The Gruesome
Stock price: 3.4574468085106385
P/E ratio: 7.028683527026699
Shares outstanding: 6154205
Book value: 10367941.489361703
P/B ratio: 2.052272040501279
Market cap (USD): 21277836.436170213
Debt to equity: 0.03843701918711166
Current ratio: 4.589928073096789
Quick ratio: 3.8142495961301948
Effective tax rate (%): -8.401876962788352
Interest coverage ratio: -1156.907353792704
COGS to revenue (%): 81.83551206063879
Free cash flow (dilution-adjusted): 5431463.829787235
Buyback yield (%): 0
Retained earnings: -267147.87234042556
Inventory turnover: 1.3914493016001226
Receivables turnover: 5.461144844398224
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -39.57492361493986
FCF margin (%): 209.0847625323062
Rule of 40 score: 209.0847625323062
Financial ratios for ALSMA.PA — annual report dated 2023-12-31
Total revenue: 5981353.333333333
Gross profit: 4937525.555555555
Operating income: -1195071.111111111
Net income: -495780
Capital expenditures: 1694471.111111111
Operating cash flow: 386187.77777777775
Depreciation & amortization: 1532702.2222222222
Net tangible assets: 7760144.444444444
Owner earnings: -657548.8888888888
Return on net tangible assets (%): -8.473410431936403
Buffett classification: The Gruesome
Stock price: 3.422222222222222
Shares outstanding: 6154205
Book value: 10296310
P/B ratio: 2.045495630095744
Market cap (USD): 21061057.111111112
Debt to equity: 0.3302704237408029
Current ratio: 7.359308975439531
Quick ratio: 6.469797954826065
Interest coverage ratio: -23.158796804685313
COGS to revenue (%): 17.451364592702728
Free cash flow (dilution-adjusted): -1308283.3333333333
Buyback yield (%): 0.2779537593538752
Retained earnings: -495780
Inventory turnover: 0.7524499104936665
Receivables turnover: 8.934312311524845
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.673604546037003
FCF margin (%): -21.87269770609327
Revenue growth (%): 130.25281590999896
Rule of 40 score: 108.38011820390568
Financial ratios for ALSMA.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4776594.791666667
Buffett classification: The Gruesome
Stock price: 2.6875
Shares outstanding: 6154205
Book value: 7133268.75
P/B ratio: 2.318632105021979
Market cap (USD): 16539425.9375
Debt to equity: 0.3375270044793046
Current ratio: 3.193800771506893
Quick ratio: 2.6741796081016713
Buyback yield (%): 0
Retained earnings: -2446712.5
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALSMA.PA — annual report dated 2024-12-31
Total revenue: 5726221.875
Gross profit: 4391809.375
Operating income: -3316811.4583333335
Net income: -2446711.4583333335
Capital expenditures: 1618747.9166666667
Operating cash flow: -1495458.3333333335
Depreciation & amortization: 1493183.3333333335
Net tangible assets: 4776594.791666667
Owner earnings: -2572276.041666667
Return on net tangible assets (%): -53.851669523115206
Buffett classification: The Gruesome
Stock price: 2.6875
Shares outstanding: 6154205
Book value: 7133268.75
P/B ratio: 2.318632105021979
Market cap (USD): 16539425.9375
Debt to equity: 0.3375270044793046
Current ratio: 3.193800771506893
Quick ratio: 2.6741796081016713
Interest coverage ratio: -28.376859253714052
COGS to revenue (%): 23.30354165677522
Free cash flow (dilution-adjusted): -3114206.25
Buyback yield (%): 0.7655130160610107
Retained earnings: -2446712.5
Inventory turnover: 0.9515792726454274
Receivables turnover: 3.204188454209875
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -34.58869010071235
FCF margin (%): -54.38500843979261
Revenue growth (%): -4.265447033725919
Rule of 40 score: -58.65045547351853
Financial ratios for ALVO — annual report dated 2022-12-31
Total revenue: 88328723.40425533
Gross profit: 20142553.19148936
Operating income: -368555319.1489362
Net income: -546361702.1276596
Capital expenditures: 39894680.85106383
Operating cash flow: -332328723.40425533
Depreciation & amortization: 21711702.127659574
Net tangible assets: -640118085.106383
Owner earnings: -564544680.8510638
Buffett classification: The Gruesome
Stock price: 10
Shares outstanding: 338219831
Book value: -600442553.1914893
Market cap (USD): 3382198310
Debt to equity: -1.4264336942964058
Current ratio: 1.379224598610829
Quick ratio: 0.9520126244814519
Interest coverage ratio: -4.471719544621421
COGS to revenue (%): 77.19591949800672
R&D to revenue (%): 217.54085921786364
SG&A to revenue (%): 220.87222536704041
Free cash flow (dilution-adjusted): -395434042.55319154
Buyback yield (%): 0
Retained earnings: -1759695744.6808512
Inventory turnover: 0.8968098502868337
Receivables turnover: 1.1630829142560972
Capitalized R&D asset: 192151063.82978725
ROCI (R&D-adjusted, %): -26.851404162573118
FCF margin (%): -447.68454395452187
Rule of 40 score: -447.68454395452187
Financial ratios for ALVO — annual report dated 2023-12-31
Total revenue: 101593333.33333333
Gross profit: -77135555.55555555
Operating income: -394288888.8888889
Net income: -613034444.4444444
Capital expenditures: 36778888.88888889
Operating cash flow: -346872222.2222222
Depreciation & amortization: 26900000
Net tangible assets: -1070696666.6666666
Owner earnings: -622913333.3333333
Buffett classification: The Gruesome
Stock price: 11.48
Shares outstanding: 338219831
Book value: -1036103333.3333333
Market cap (USD): 3882763659.88
Debt to equity: -1.153331982116756
Current ratio: 0.7466641118988312
Quick ratio: 0.46142556045219396
Interest coverage ratio: -2.6647743059466684
COGS to revenue (%): 175.92580440536346
R&D to revenue (%): 230.57834066102325
SG&A to revenue (%): 79.88056959118053
Free cash flow (dilution-adjusted): -418545555.5555556
Buyback yield (%): 0
Retained earnings: -2450938888.888889
Inventory turnover: 2.1610844652237584
Receivables turnover: 1.0483506655812513
Capitalized R&D asset: 362993434.9881797
ROCI (R&D-adjusted, %): -26.77149626046498
Rosenberg metric: -0.5062584968731506
FCF margin (%): -411.9813198591334
Revenue growth (%): 15.01732326456216
Rule of 40 score: -396.96399659457126
Financial ratios for ALVO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.9
Shares outstanding: 338219831
Market cap (USD): 4024815988.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALVO — quarterly report dated 2024-12-31
Total revenue: 157505208.33333334
Gross profit: 73828125
Operating income: 14032291.666666668
Net income: -69757291.66666667
Capital expenditures: 30802083.333333336
Operating cash flow: -40835416.66666667
Depreciation & amortization: 8494791.666666668
Net tangible assets: -463252083.3333334
Owner earnings: -92064583.33333334
Capex to operating income (%): 219.50857397372135
Buffett classification: The Gruesome
Stock price: 13.23
Shares outstanding: 338219831
Book value: -429969791.66666675
Market cap (USD): 4474648364.13
Debt to equity: -2.8835262167158056
Current ratio: 2.35278909594821
Quick ratio: 1.6915086144491096
COGS to revenue (%): 53.12655004794815
R&D to revenue (%): 26.627426341721506
SG&A to revenue (%): 9.932872590192124
Free cash flow (dilution-adjusted): -72915625
Buyback yield (%): 0
Retained earnings: -2539280208.3333335
Inventory turnover: 0.6281228252625324
Receivables turnover: 0.6006896579121958
Capitalized R&D asset: 41939583.333333336
ROCI (R&D-adjusted, %): 3.7736231737538533
FCF margin (%): -46.29410403095135
Rule of 40 score: -46.29410403095135
Financial ratios for ALVO — annual report dated 2024-12-31
Total revenue: 510085416.6666667
Gross profit: 317055208.3333334
Operating income: 72545833.33333334
Net income: -241525000
Capital expenditures: 55896875
Operating cash flow: -246711458.33333334
Depreciation & amortization: 32605208.333333336
Net tangible assets: -463252083.3333334
Owner earnings: -264816666.66666666
Capex to operating income (%): 77.0504278904141
Buffett classification: The Gruesome
Stock price: 13.23
Shares outstanding: 338219831
Book value: -429969791.66666675
Market cap (USD): 4474648364.13
Debt to equity: -2.8835262167158056
Current ratio: 2.35278909594821
Quick ratio: 1.6915086144491096
Interest coverage ratio: 0.45227194503432117
COGS to revenue (%): 37.84272241985615
R&D to revenue (%): 34.984336773661276
SG&A to revenue (%): 12.549777202347645
Free cash flow (dilution-adjusted): -314030208.3333334
Buyback yield (%): 0
Retained earnings: -2539280208.3333335
Inventory turnover: 1.4489831025342288
Receivables turnover: 1.9453517612893743
Capitalized R&D asset: 398808839.9527187
ROCI (R&D-adjusted, %): 3.359860802809569
Rosenberg metric: 1.6827621106404782
FCF margin (%): -61.56423964940513
Revenue growth (%): 402.0855207034583
Rule of 40 score: 340.5212810540532
Financial ratios for ALVO — quarterly report dated 2025-03-31
Total revenue: 144309782.60869566
Gross profit: 73171739.13043478
Operating income: 11502173.913043479
Net income: 119217391.30434783
Capital expenditures: 25203260.869565215
Operating cash flow: 13640217.391304348
Depreciation & amortization: 8977173.913043479
Net tangible assets: -364033695.6521739
Owner earnings: 102991304.3478261
Return on net tangible assets (%): -28.291695405645083
Capex to operating income (%): 219.11736911736907
Buffett classification: The Gruesome
Stock price: 9.67
P/E ratio: 6.858449362938548
Shares outstanding: 338219831
Book value: -328572826.0869565
Market cap (USD): 3270585765.77
Debt to equity: -4.058877821408132
Current ratio: 1.7263028004755239
Quick ratio: 1.1918122582878123
Effective tax rate (%): -17.404009805075944
Interest coverage ratio: 0.29775739328624895
COGS to revenue (%): 49.29537152110871
R&D to revenue (%): 28.75004707566
SG&A to revenue (%): 14.01498889014424
Free cash flow (dilution-adjusted): -13183695.652173914
Buyback yield (%): 0
Retained earnings: -2530466304.347826
Inventory turnover: 0.4606543069104832
Receivables turnover: 0.5803909053949491
Capitalized R&D asset: 69588651.26811594
ROCI (R&D-adjusted, %): 2.219778266540347
Rosenberg metric: -0.015650748467105704
FCF margin (%): -9.135690882386172
Revenue growth (%): -8.377771036442034
Rule of 40 score: -17.513461918828206
Financial ratios for ALVO — quarterly report dated 2025-06-30
Total revenue: 203810588.23529413
Gross profit: 116957647.05882353
Operating income: 21243529.411764707
Net income: 37691764.705882356
Capital expenditures: 16021176.470588235
Operating cash flow: 65578823.52941176
Depreciation & amortization: 10467058.823529411
Net tangible assets: -283301176.47058827
Owner earnings: 32137647.058823526
Return on net tangible assets (%): -11.343986445520459
Capex to operating income (%): 75.41673589189787
Buffett classification: The Gruesome
Stock price: 9.12
P/E ratio: 35.39298765382988
Shares outstanding: 338219831
Book value: -203915294.11764693
Market cap (USD): 3084564858.72
Debt to equity: -7.315713560417248
Current ratio: 1.8211360898519742
Quick ratio: 1.2653164086377429
Effective tax rate (%): -244.12459720730396
Interest coverage ratio: 0.5384523632026241
COGS to revenue (%): 42.614538296803836
R&D to revenue (%): 31.585843834240556
SG&A to revenue (%): 15.435323454880251
Free cash flow (dilution-adjusted): 29445882.352941178
Buyback yield (%): 0
Retained earnings: -2701165882.352941
Inventory turnover: 0.47478937552254163
Receivables turnover: 0.9602463264435096
Capitalized R&D asset: 106013074.00895141
ROCI (R&D-adjusted, %): 2.568180862529372
Rosenberg metric: 1.0553585353449737
FCF margin (%): 14.447670559169701
Revenue growth (%): 41.23130431700418
Rule of 40 score: 55.67897487617388
Financial ratios for ALVO — quarterly report dated 2025-09-30
Total revenue: 133816470.5882353
Gross profit: 92632941.1764706
Operating income: 1544705.8823529412
Net income: -6178823.529411765
Capital expenditures: 22265882.352941178
Operating cash flow: -65382352.941176474
Depreciation & amortization: 12096470.588235294
Net tangible assets: -295805882.35294116
Owner earnings: -16348235.294117648
Capex to operating income (%): 1441.4318354912416
Buffett classification: The Gruesome
Stock price: 8.19
P/E ratio: 34.20916873120418
Shares outstanding: 338219831
Book value: -207956470.58823514
Market cap (USD): 2770020415.89
Debt to equity: -7.253559851326358
Current ratio: 1.4207498955829105
Quick ratio: 0.7375858768897849
Interest coverage ratio: 0.03334603174603175
COGS to revenue (%): 30.776128850752567
R&D to revenue (%): 45.38173442115628
SG&A to revenue (%): 22.79153186102124
Free cash flow (dilution-adjusted): -102015294.11764707
Buyback yield (%): 0
Retained earnings: -2707344705.882353
Inventory turnover: 0.16851763595838806
Receivables turnover: 0.9296532108442106
Capitalized R&D asset: 117551095.39641945
ROCI (R&D-adjusted, %): 0.475569786128633
Rosenberg metric: -0.37785778248871493
FCF margin (%): -76.23522999015333
Revenue growth (%): -34.34272883126779
Rule of 40 score: -110.57795882142112
Financial ratios for ALVO — annual report dated 2025-12-31
Total revenue: 689789411.7647059
Gross profit: 412662352.9411765
Operating income: 92008235.29411764
Net income: 32845882.352941178
Capital expenditures: 75847058.8235294
Operating cash flow: -59055294.11764706
Depreciation & amortization: 44530588.23529412
Net tangible assets: -446065882.3529412
Owner earnings: 1529411.7647058815
Return on net tangible assets (%): -0.34286678834041906
Capex to operating income (%): 82.43507614407916
Buffett classification: The Gruesome
Stock price: 5.13
P/E ratio: 52.824512807604144
Shares outstanding: 338219831
Book value: -334690588.2352941
Market cap (USD): 1735067733.03
Debt to equity: -5.0938882971805395
Current ratio: 1.8877228868908635
Quick ratio: 1.1640467248534916
Effective tax rate (%): 79.52371871974653
Interest coverage ratio: 0.5713962153868634
COGS to revenue (%): 40.17560346636058
R&D to revenue (%): 31.415043977616357
SG&A to revenue (%): 14.483192653853436
Free cash flow (dilution-adjusted): -180828235.29411766
Buyback yield (%): 0
Retained earnings: -2835047058.8235297
Inventory turnover: 1.070455433666282
Receivables turnover: 3.8125772176921173
Capitalized R&D asset: 413562380.39215684
ROCI (R&D-adjusted, %): 5.478484933275112
Rosenberg metric: 0.535764329548014
FCF margin (%): -26.214991446664882
Revenue growth (%): 35.23017699121422
Rule of 40 score: 9.01518554454934
Financial ratios for ALVO — quarterly report dated 2025-12-31
Total revenue: 195968235.29411766
Gross profit: 123874117.64705883
Operating income: 56770588.23529412
Net income: -127702352.94117647
Capital expenditures: 10281176.470588235
Operating cash flow: -74015294.11764707
Depreciation & amortization: 12250588.235294119
Net tangible assets: -446065882.3529412
Owner earnings: -125732941.1764706
Capex to operating income (%): 18.110040410320174
Buffett classification: The Great
Stock price: 5.13
P/E ratio: 75.3460689003625
Shares outstanding: 338219831
Book value: -334690588.2352941
Market cap (USD): 1735067733.03
Debt to equity: -5.0938882971805395
Current ratio: 1.8877228868908635
Quick ratio: 1.1640467248534916
Effective tax rate (%): 373.3905903687286
Interest coverage ratio: 1.6978642553041765
COGS to revenue (%): 36.788675235482344
R&D to revenue (%): 23.824389306790415
SG&A to revenue (%): 8.192804356048098
Free cash flow (dilution-adjusted): -93989411.76470588
Buyback yield (%): 0
Retained earnings: -2835047058.8235297
Inventory turnover: 0.27847710107519064
Receivables turnover: 1.083148010872251
Capitalized R&D asset: 108620000
ROCI (R&D-adjusted, %): 3.0788197940222326
Rosenberg metric: 0.5144423564966388
FCF margin (%): -47.96155439356918
Revenue growth (%): 46.44552679701786
Rule of 40 score: -1.516027596551318
Financial ratios for AMRZ — quarterly report dated 2025-06-30
Total revenue: 4025000000
Gross profit: 1207500000
Operating income: 833750000
Net income: 536250000
Capital expenditures: 287500000
Operating cash flow: 507500000
Depreciation & amortization: 280000000
Net tangible assets: 2010000000
Owner earnings: 528750000
Return on net tangible assets (%): 26.30597014925373
Capex to operating income (%): 34.48275862068966
Buffett classification: The Good
Stock price: 49.06
P/E ratio: 62.08814058985504
Shares outstanding: 553536609
Book value: 15541250000
P/B ratio: 1.7473823558298078
Market cap (USD): 27156506037.54
Debt to equity: 0.5769323574358561
Current ratio: 1.376391982182628
Quick ratio: 0.8542793509385938
Effective tax rate (%): 22.22222222222222
Interest coverage ratio: 5.512396694214876
COGS to revenue (%): 70
SG&A to revenue (%): 9.285714285714286
Free cash flow (dilution-adjusted): 211250000
Buyback yield (%): 0
Retained earnings: 73750000
Inventory turnover: 1.3735527117611213
Receivables turnover: 1.7019027484143763
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2317457241145404
FCF margin (%): 5.248447204968945
Revenue growth (%): 70.20663142719845
Rule of 40 score: 75.45507863216739
Financial ratios for AMRZ — quarterly report dated 2025-09-30
Total revenue: 4593750000
Gross profit: 1357500000
Operating income: 967500000
Net income: 681250000
Capital expenditures: 225000000
Operating cash flow: 1067500000
Depreciation & amortization: 276250000
Net tangible assets: 2682500000
Owner earnings: 732500000
Return on net tangible assets (%): 27.306616961789377
Capex to operating income (%): 23.25581395348837
Buffett classification: The Great
Stock price: 48.05
P/E ratio: 23.77665783721658
Shares outstanding: 553536609
Book value: 16122500000
P/B ratio: 1.649709044034734
Market cap (USD): 26597434062.449997
Debt to equity: 0.5340362846953016
Current ratio: 1.4495558375634519
Quick ratio: 0.9701776649746193
Effective tax rate (%): 21.77068214804064
Interest coverage ratio: 8.696629213483146
COGS to revenue (%): 70.44897959183673
SG&A to revenue (%): 8.489795918367347
Free cash flow (dilution-adjusted): 832500000
Buyback yield (%): 0
Retained earnings: 751250000
Inventory turnover: 1.7134348113831899
Receivables turnover: 1.7375886524822695
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.7063640281568744
FCF margin (%): 18.122448979591837
Revenue growth (%): 14.130434782608695
Rule of 40 score: 32.25288376220053
Financial ratios for AMRZ — annual report dated 2025-12-31
Total revenue: 14955696202.531645
Gross profit: 3840506329.113924
Operating income: 2412658227.848101
Net income: 1500000000
Capital expenditures: 945569620.2531645
Operating cash flow: 2794936708.8607593
Depreciation & amortization: 1139240506.329114
Net tangible assets: 3177215189.8734174
Owner earnings: 1693670886.0759494
Return on net tangible assets (%): 53.30677290836654
Capex to operating income (%): 39.19202518363064
Buffett classification: The Good
Stock price: 53.55
P/E ratio: 19.761256941299997
Shares outstanding: 553536609
Book value: 16777215189.873419
P/B ratio: 1.7667941357658439
Market cap (USD): 29641885411.949997
Debt to equity: 0.47857250641315824
Current ratio: 1.6384319215960799
Quick ratio: 1.095554777738887
Effective tax rate (%): 21.77688710754843
Interest coverage ratio: 4.61501210653753
COGS to revenue (%): 74.3207786711807
SG&A to revenue (%): 9.547185780787135
Free cash flow (dilution-adjusted): 1779746835.4430377
Buyback yield (%): 0
Retained earnings: 1141772151.898734
Inventory turnover: 5.661508704061895
Receivables turnover: 10.549107142857144
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.909872849663426
FCF margin (%): 11.900126957257722
Revenue growth (%): 15.004499165058785
Rule of 40 score: 26.904626122316508
Financial ratios for AMRZ — quarterly report dated 2025-12-31
Total revenue: 3593670886.075949
Gross profit: 962025316.4556961
Operating income: 610126582.278481
Net income: 377215189.8734177
Capital expenditures: 187341772.1518987
Operating cash flow: 2283544303.797468
Depreciation & amortization: 303797468.3544304
Net tangible assets: 3177215189.8734174
Owner earnings: 493670886.0759493
Return on net tangible assets (%): 15.53784860557769
Capex to operating income (%): 30.705394190871367
Buffett classification: The Good
Stock price: 53.55
P/E ratio: 19.816060853364736
Shares outstanding: 553536609
Book value: 16777215189.873419
P/B ratio: 1.7667941357658439
Market cap (USD): 29641885411.949997
Debt to equity: 0.47857250641315824
Current ratio: 1.6384319215960799
Quick ratio: 1.095554777738887
Effective tax rate (%): 25.510204081632654
Interest coverage ratio: 5.670588235294118
COGS to revenue (%): 73.23001056710109
SG&A to revenue (%): 9.792180345191968
Free cash flow (dilution-adjusted): 2074683544.3037975
Buyback yield (%): 0
Retained earnings: 1141772151.898734
Inventory turnover: 1.3404255319148937
Receivables turnover: 2.5348214285714286
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2531787584143603
FCF margin (%): 57.731595632264884
Revenue growth (%): -21.77042969086369
Rule of 40 score: 35.96116594140119
Financial ratios for ATRA — annual report dated 2021-12-31
Capital expenditures: 10580000
Buffett classification: The Gruesome
Stock price: 394
Shares outstanding: 9010172
Market cap (USD): 3550007768
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATRA — annual report dated 2022-12-31
Total revenue: 63573000
Gross profit: 63573000
Operating income: -280513000
Net income: -228302000
Capital expenditures: 90572000
Operating cash flow: -270430000
Depreciation & amortization: 5653000
Net tangible assets: 126640000
Owner earnings: -313221000
Return on net tangible assets (%): -247.33180669614657
Buffett classification: The Gruesome
Stock price: 82
Shares outstanding: 9010172
Book value: 126640000
P/B ratio: 5.834129058749211
Market cap (USD): 738834104
Debt to equity: 0.5662034112444725
Current ratio: 3.7391656951695476
Quick ratio: 3.7190683765015966
Interest coverage ratio: -752.0455764075067
COGS to revenue (%): 0
R&D to revenue (%): 428.6929986000346
SG&A to revenue (%): 112.55249870227928
Free cash flow (dilution-adjusted): -328461000
Buyback yield (%): 0
Retained earnings: -1693024000
Inventory turnover: 0
Receivables turnover: 1.580592227940628
Capitalized R&D asset: 272533000
ROCI (R&D-adjusted, %): -17.3364769889206
FCF margin (%): -516.667453164079
Rule of 40 score: -516.667453164079
Financial ratios for ATRA — annual report dated 2023-12-31
Total revenue: 8573000
Gross profit: -313000
Operating income: -276006000
Net income: -276126000
Capital expenditures: 1198000
Operating cash flow: -192977000
Depreciation & amortization: 4829000
Net tangible assets: -99231000
Owner earnings: -272495000
Buffett classification: The Gruesome
Stock price: 12.82
Shares outstanding: 9010172
Book value: -99231000
Market cap (USD): 115510405.04
Debt to equity: -0.5832048452600498
Current ratio: 0.716247380928944
Quick ratio: 0.648003881146907
Interest coverage ratio: -52.2244087038789
COGS to revenue (%): 103.65099731715853
R&D to revenue (%): 2622.0109646564797
SG&A to revenue (%): 593.8178000699872
Free cash flow (dilution-adjusted): -239586000
Buyback yield (%): 0
Retained earnings: -1969150000
Inventory turnover: 0.9155161755615083
Receivables turnover: 0.25134865720652044
Capitalized R&D asset: 407382110
ROCI (R&D-adjusted, %): -50.386293419807714
Rosenberg metric: -0.2344156487471242
FCF margin (%): -2794.6576460982155
Revenue growth (%): -86.51471536658644
Rule of 40 score: -2881.172361464802
Financial ratios for ATRA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.13
Shares outstanding: 9010172
Market cap (USD): 73252698.36000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATRA — quarterly report dated 2024-12-31
Capital expenditures: 90000
Buffett classification: The Gruesome
Stock price: 13.31
Shares outstanding: 9010172
Market cap (USD): 119925389.32000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATRA — annual report dated 2024-12-31
Total revenue: 128940000
Gross profit: 107931000
Operating income: -83438000
Net income: -85403000
Capital expenditures: 246000
Operating cash flow: -68717000
Depreciation & amortization: 5051000
Net tangible assets: -97283000
Owner earnings: -80598000
Buffett classification: The Gruesome
Stock price: 13.31
Shares outstanding: 9010172
Book value: -97283000
Market cap (USD): 119925389.32000001
Debt to equity: -0.4505514838152606
Current ratio: 0.4822179618648476
Quick ratio: 0.4030421923997206
Interest coverage ratio: -18.079739978331528
COGS to revenue (%): 16.29362494183341
R&D to revenue (%): 117.48332557778811
SG&A to revenue (%): 30.933767643865362
Free cash flow (dilution-adjusted): -95964000
Buyback yield (%): 0
Retained earnings: -2054553000
Inventory turnover: 1.9717503519474424
Receivables turnover: 87.00404858299595
Capitalized R&D asset: 392024840
ROCI (R&D-adjusted, %): -40.43717612092293
Rosenberg metric: 0.48154458704984765
FCF margin (%): -74.4253140995812
Revenue growth (%): 1404.0242622185933
Rule of 40 score: 1329.5989481190122
Financial ratios for ATRA — quarterly report dated 2025-03-31
Total revenue: 98149000
Gross profit: 77710000
Operating income: 38802000
Net income: 38010000
Capital expenditures: 0
Operating cash flow: -28138000
Depreciation & amortization: 1795000
Net tangible assets: -55072000
Owner earnings: 39805000
Return on net tangible assets (%): -72.27810865775712
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.94
P/E ratio: 0.3520154017363852
Shares outstanding: 9010172
Book value: -55072000
Market cap (USD): 53520421.68000001
Debt to equity: -0.7376525276002325
Current ratio: 0.5675686962331914
Quick ratio: 0.5675686962331914
Effective tax rate (%): 0
Interest coverage ratio: 38.15339233038348
COGS to revenue (%): 20.824460768831063
R&D to revenue (%): 27.950361185544427
SG&A to revenue (%): 11.691407961364863
Free cash flow (dilution-adjusted): -32347000
Buyback yield (%): 0
Retained earnings: -2016543000
Receivables turnover: 11.059042253521127
Capitalized R&D asset: 27433000
ROCI (R&D-adjusted, %): 137.3064928609795
FCF margin (%): -32.95703471252891
Rule of 40 score: -32.95703471252891
Financial ratios for ATRA — quarterly report dated 2025-06-30
Total revenue: 17575000
Gross profit: 17021000
Operating income: 3776000
Net income: 2387000
Capital expenditures: 349000
Operating cash flow: -7318000
Depreciation & amortization: 236000
Net tangible assets: -35041000
Owner earnings: 2274000
Return on net tangible assets (%): -6.489540823606632
Capex to operating income (%): 9.242584745762713
Buffett classification: The Great
Stock price: 7.72
P/E ratio: 1.7218736005148896
Shares outstanding: 9010172
Book value: -35041000
Market cap (USD): 69558527.84
Debt to equity: -0.5042093547558574
Current ratio: 1.701023140836366
Quick ratio: 1.701023140836366
Effective tax rate (%): 0.12552301255230125
Interest coverage ratio: 3.8847736625514404
COGS to revenue (%): 3.152204836415363
R&D to revenue (%): 41.59317211948791
SG&A to revenue (%): 33.76955903271693
Free cash flow (dilution-adjusted): -10119000
Buyback yield (%): 0
Retained earnings: -2014156000
Capitalized R&D asset: 25690110
ROCI (R&D-adjusted, %): -1.0306249688990698
Rosenberg metric: -2.2122626034338206
FCF margin (%): -57.57610241820769
Revenue growth (%): -82.09355164087255
Rule of 40 score: -139.66965405908024
Financial ratios for ATRA — quarterly report dated 2025-09-30
Total revenue: 3453000
Gross profit: 3338000
Operating income: -3574000
Net income: -4303000
Capital expenditures: 44000
Operating cash flow: -9787000
Depreciation & amortization: 36000
Net tangible assets: -36634000
Owner earnings: -4311000
Buffett classification: The Gruesome
Stock price: 14.33
P/E ratio: 3.5772085321660114
Shares outstanding: 9010172
Book value: -36634000
Market cap (USD): 129115764.76
Debt to equity: -0.4629033138614402
Current ratio: 1.0207675693636817
Quick ratio: 1.0207675693636817
Interest coverage ratio: -3.931793179317932
COGS to revenue (%): 3.3304373008977697
R&D to revenue (%): 84.70894874022589
SG&A to revenue (%): 115.46481320590792
Free cash flow (dilution-adjusted): -11012000
Buyback yield (%): 0
Retained earnings: -2018459000
Receivables turnover: 1.8050182958703607
Capitalized R&D asset: 16875590
ROCI (R&D-adjusted, %): -45.55711993442259
Rosenberg metric: -1.8718194254445963
FCF margin (%): -318.9110918042282
Revenue growth (%): -80.35277382645803
Rule of 40 score: -399.2638656306862
Financial ratios for ATRA — quarterly report dated 2025-12-31
Total revenue: 1595000
Gross profit: 1491000
Operating income: -2563000
Net income: -3406000
Capital expenditures: 555000
Operating cash flow: -5697000
Depreciation & amortization: 49000
Net tangible assets: -38502000
Owner earnings: -3912000
Buffett classification: The Gruesome
Stock price: 18.09
P/E ratio: 4.986356200440529
Shares outstanding: 9010172
Book value: -38502000
Market cap (USD): 162994011.48
Debt to equity: -0.2694665212196769
Current ratio: 0.8183889559040343
Quick ratio: 0.8183889559040343
Interest coverage ratio: -2.8668903803131993
COGS to revenue (%): 6.52037617554859
R&D to revenue (%): -13.981191222570533
SG&A to revenue (%): 268.1504702194357
Free cash flow (dilution-adjusted): -7214000
Buyback yield (%): 0
Retained earnings: -2021865000
Receivables turnover: 1.2729449321628092
Capitalized R&D asset: 4149050
ROCI (R&D-adjusted, %): -64.71465838093577
Rosenberg metric: -0.6314529914529915
FCF margin (%): -452.2884012539185
Revenue growth (%): -53.80828265276571
Rule of 40 score: -506.09668390668423
Financial ratios for ATRA — annual report dated 2025-12-31
Total revenue: 120772000
Gross profit: 99560000
Operating income: 35862000
Net income: 32688000
Capital expenditures: 948000
Operating cash flow: -50940000
Depreciation & amortization: 2116000
Net tangible assets: -38502000
Owner earnings: 33856000
Return on net tangible assets (%): -87.93309438470729
Capex to operating income (%): 2.643466622051196
Buffett classification: The Great
Stock price: 18.09
P/E ratio: 4.986356200440529
Shares outstanding: 9010172
Book value: -38502000
Market cap (USD): 162994011.48
Debt to equity: -0.2694665212196769
Current ratio: 0.8183889559040343
Quick ratio: 0.8183889559040343
Effective tax rate (%): 0.09474617194902044
Interest coverage ratio: 9.457278481012658
COGS to revenue (%): 17.5636736992018
R&D to revenue (%): 31.00470307687212
SG&A to revenue (%): 21.737654423210678
Free cash flow (dilution-adjusted): -60692000
Buyback yield (%): 0
Retained earnings: -2021865000
Receivables turnover: 96.38627294493216
Capitalized R&D asset: 213117660
ROCI (R&D-adjusted, %): -29.57338192968576
Rosenberg metric: -0.05526032624122839
FCF margin (%): -50.253369986420694
Revenue growth (%): -6.334729331472003
Rule of 40 score: -56.5880993178927
Financial ratios for BCA.AX — annual report dated 2021-06-30
Operating income: -638114.2857142857
Net income: -633006.0150375939
Capital expenditures: 26870.67669172932
Net tangible assets: 3767288.7218045113
Owner earnings: -659876.6917293232
Return on net tangible assets (%): -17.51595750838141
Buffett classification: The Gruesome
Stock price: 0.18796992481203006
Shares outstanding: 162271026
Book value: 3767288.721804511
P/B ratio: 8.09655824355842
Market cap (USD): 30502072.556390975
Debt to equity: 0
Current ratio: 14.075227668065077
Quick ratio: 14.075227668065077
Free cash flow (dilution-adjusted): -280476.6917293233
Buyback yield (%): 0
Retained earnings: -773428.5714285714
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.938289917121946
Rule of 40 score: 0
Financial ratios for BCA.AX — annual report dated 2022-06-30
Operating income: -845395.8620689656
Net income: -836404.1379310346
Capital expenditures: 65381.379310344826
Net tangible assets: 5093890.344827587
Owner earnings: -901785.5172413794
Return on net tangible assets (%): -17.70327698861963
Buffett classification: The Gruesome
Stock price: 0.15862068965517243
Shares outstanding: 162271026
Book value: 5093890.344827587
P/B ratio: 5.053022407776943
Market cap (USD): 25739542.055172417
Debt to equity: 0
Current ratio: 5.416368516700669
Quick ratio: 5.416368516700669
Free cash flow (dilution-adjusted): -2114305.5172413792
Buyback yield (%): 0
Retained earnings: -1545824.8275862068
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.596271314073206
Rule of 40 score: 0
Financial ratios for BCA.AX — annual report dated 2023-06-30
Operating income: -1365890.0662251655
Net income: -1338986.0927152317
Capital expenditures: 827.1523178807947
Net tangible assets: 3711256.953642384
Owner earnings: -1339813.2450331126
Return on net tangible assets (%): -36.10133336949799
Buffett classification: The Gruesome
Stock price: 0.11258278145695365
Shares outstanding: 162271026
Book value: 3711256.953642384
P/B ratio: 4.922570354236386
Market cap (USD): 18268923.456953645
Debt to equity: 0
Current ratio: 2.584115279021409
Quick ratio: 2.584115279021409
Free cash flow (dilution-adjusted): -2399105.298013245
Buyback yield (%): 0
Retained earnings: -2823387.417218543
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -36.80397459099735
Rule of 40 score: 0
Financial ratios for BCA.AX — annual report dated 2024-06-30
Operating income: -1671248
Net income: -1329086
Capital expenditures: 442
Net tangible assets: 4032227.3333333335
Owner earnings: -1329528
Return on net tangible assets (%): -32.972545694761585
Buffett classification: The Gruesome
Stock price: 0.05333333333333334
Shares outstanding: 162271026
Book value: 4001052.6666666665
P/B ratio: 2.163044438805188
Market cap (USD): 8654454.72
Debt to equity: 0
Current ratio: 2.860537001279331
Quick ratio: 2.860537001279331
Free cash flow (dilution-adjusted): -1504071.3333333333
Buyback yield (%): 0
Retained earnings: -4171296
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -41.68070088338667
Rule of 40 score: 0
Financial ratios for BHE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.71
Shares outstanding: 35877036
Market cap (USD): 886521559.5600001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BHE — annual report dated 2022-12-31
Total revenue: 2886331000
Gross profit: 255235000
Operating income: 98636000
Net income: 68229000
Capital expenditures: 43036000
Operating cash flow: -177467000
Depreciation & amortization: 44252000
Net tangible assets: 834300000
Owner earnings: 69445000
Return on net tangible assets (%): 8.323744456430541
Capex to operating income (%): 43.631128594022464
Buffett classification: The Good
Stock price: 24.99
P/E ratio: 13.140557968605723
Shares outstanding: 35877036
Book value: 1026416000
P/B ratio: 0.8734929401334351
Market cap (USD): 896567129.64
Debt to equity: 0.40104304687378217
Current ratio: 2.2054059610004058
Quick ratio: 1.2339548493197496
Effective tax rate (%): 19.104360816674966
Interest coverage ratio: 7.64975957809834
COGS to revenue (%): 91.15711261113158
SG&A to revenue (%): 5.2043580587257665
Free cash flow (dilution-adjusted): -242726000
Buyback yield (%): 1.0474396940885824
Retained earnings: 519895000
Inventory turnover: 3.6153893718850867
Receivables turnover: 4.272438089317169
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.672732623233064
FCF margin (%): -8.409499811352198
Rule of 40 score: -8.409499811352198